Opus Capital Group’s SELLAS Life Sciences SLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Buy	346,452 +29,352	+9%	+$131K	0.16%	50
2025 Q4	$1.2M	Buy	317,100 +67,100	+27%	+$130K	0.13%	52
2025 Q3	$403K	Buy	250,000 +10,000	+4%	+$17.8K	0.05%	84
2025 Q2	$526K	Buy	240,000 +500	+0.2%	+$767	0.06%	74
2025 Q1	$259K	Buy	239,500 +1,000	+0.4%	+$1.19K	0.03%	105
2024 Q4	$248K	Buy	238,500 +12,400	+5%	+$14.2K	0.03%	101
2024 Q3	$283K	Buy	226,100 +5,100	+2%	+$6.23K	0.04%	95
2024 Q2	$263K	Buy	221,000 +20,400	+10%	+$27.8K	0.04%	102
2024 Q1	$203K	Buy	200,600 +65,600	+49%	+$55.1K	0.03%	118
2023 Q4	$143K	Buy	135,000 +100,500	+291%	+$109K	0.02%	117
2023 Q3	$57K	Buy	34,500 +3,500	+11%	+$5.52K	0.01%	111
2023 Q2	$49K	Buy	31,000 +6,000	+24%	+$9.64K	0.01%	119
2023 Q1	$36K	Buy	25,000 +5,328	+27%	+$13.2K	0.01%	119
2022 Q4	$46K	Buy	+19,672	New	+$55.2K	0.01%	115